Product Information
ENALAPRIL 1 MG/ML ORAL SOLN is a generic product labeled by Bionpharma Inc., priced at $0.7946 per ML under NDC 69452023746. Its NADAC has been published 250 times since Dec 22, 2021.
FDA first approved this application on Aug 10, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/mL
Manufacturer
Bionpharma Inc.NDC
69452023746
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ENALAPRIL MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA212408FDA Approved
8/10/2021
TE Code
AB
On Market Since
8/11/2021
Pharmacological Classes
Price Statistics
The NADAC for ENALAPRIL 1 MG/ML ORAL SOLN has been published 250 times since Dec 22, 2021, and over the history we have for it it has declined 72.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7946 per ML |
|---|---|
| All-time high | $3.2167 (Jul 13, 2022) |
| All-time low | $0.7946 (Sep 23, 2026) |
| 52-week high | $1.1387 |
| 52-week low | $0.7946 |
| Median price | $1.4168 |
| Average price | $1.6353 |
| Largest weekly change | +51.0% (Oct 19, 2022) |
| Weeks tracked | 250 |
| Tracking since | Dec 22, 2021 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bionpharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Enalapril maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ENALAPRIL 1 MG/ML ORAL SOLN?
The current National Average Drug Acquisition Cost (NADAC) for ENALAPRIL 1 MG/ML ORAL SOLN, manufactured by Bionpharma Inc., is $0.7946 per ML (NDC 69452023746), effective Sep 30, 2026.
How has the price of ENALAPRIL 1 MG/ML ORAL SOLN changed over time?
Over the history we have for it, the NADAC for ENALAPRIL 1 MG/ML ORAL SOLN has declined 72.9%. It has been tracked across 250 weekly CMS publications since Dec 22, 2021.
What are the highest and lowest recorded NADAC prices for ENALAPRIL 1 MG/ML ORAL SOLN?
Since Dec 22, 2021, the NADAC for ENALAPRIL 1 MG/ML ORAL SOLN has ranged from a low of $0.7946 (Sep 23, 2026) to a high of $3.2167 (Jul 13, 2022), with a median of $1.4168 per ML.
Are there cheaper alternatives to ENALAPRIL 1 MG/ML ORAL SOLN?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ENALAPRIL 1 MG/ML ORAL SOLN in a comparable dosage form, but none are currently priced below it.
Who manufactures ENALAPRIL 1 MG/ML ORAL SOLN?
ENALAPRIL 1 MG/ML ORAL SOLN (NDC 69452023746) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.